.png)
TL;DRA drug interaction, in German Wechselwirkung or Interaktion, occurs when one substance changes the effect of another. The two substances can both be medicines, or one can be a medicine and the other a food, drink, or other agent. The change may make an effect stronger, weaker, delayed, or entirely new, and it can raise the risk of harm or reduce the benefit of a therapy.
For a professional, an interaction is not an abstract pharmacological curiosity. It is an operational risk that has to be caught before a medicine is dispensed or prescribed, especially for patients on long medication lists. The more medicines a patient takes, the faster the number of possible pairings grows, which is why manual recall stops being reliable and automated checking becomes necessary. This is why interactions are a mandatory section of every product's approved information and why they are coded, graded, and checked systematically in the drug databases used in German pharmacies.
Interactions are sorted along two independent axes: which partners are involved, and by what mechanism the effect arises. By partner, the common distinction is drug-drug, meaning two medicines, and drug-food, meaning a medicine and a food or stimulant such as grapefruit juice, alcohol, or tyramine-rich food. By mechanism, the distinction is pharmacokinetic versus pharmacodynamic.
| Type | What it affects | Plain description |
|---|---|---|
| Pharmacokinetic | What the body does to the drug | One substance changes the absorption, distribution, metabolism, or excretion of another, so the concentration at the site of action rises or falls. Enzyme inhibition or induction, for example at cytochrome P450, is the classic case. |
| Pharmacodynamic | What the drug does to the body | Two substances act on the same or related targets, so their effects add up, oppose one another, or combine into a new effect, without either changing the other's concentration. |
| Drug-drug | Medicine and medicine | Two active substances on the same medication list influence one another. |
| Drug-food | Medicine and food or stimulant | A food, drink, or stimulant changes a medicine's effect, for example grapefruit juice inhibiting intestinal metabolism. |
The mechanistic categories and the partner categories are not mutually exclusive: a drug-food interaction can be pharmacokinetic, such as grapefruit juice inhibiting CYP3A4, or pharmacodynamic, such as alcohol adding to the sedation of a benzodiazepine. What matters in practice is less the label than the consequence, meaning whether the combined effect calls for a changed dose, closer monitoring, or a different medicine altogether.
German interaction checking follows a traffic-light logic (Ampelprinzip): every interaction carries a severity grade, and that grade is shown as a colour so the most dangerous combinations stand out at a glance. In the ABDA-Datenbank, maintained by ABDATA Pharma-Daten-Service, interactions are classified into these severity grades (Schweregrade).
The colour of the ring shown in the pharmacy software encodes this grade, with the most severe interactions flagged red and moderate ones orange. Severity is only half of the assessment, because each interaction also carries an indication of how well the effect is documented, so a professional can weigh a well-evidenced moderate interaction against a poorly-evidenced severe one. ABDATA has additionally published a finer, action-oriented classification, but the underlying idea is unchanged: grade the risk, show it by colour, and recommend a measure. Which grade applies can itself depend on the dose, the route, and the patient, so the same pair of substances is not always the same risk.
Interactions are not optional content. In the Summary of Product Characteristics (SmPC), the German Fachinformation, section 4.5 "Interaction with other medicinal products and other forms of interaction" is a mandatory section, fixed by Article 11 of Directive 2001/83/EC and mirrored in § 11a AMG. That is what makes systematic checking possible: because every product has to declare its interactions in a defined section, the information can be coded into a database and matched against a patient's medication list.
The two checks run on different axes and should not be confused. The interaction check evaluates a medication list agent against agent: it takes every active substance a patient is taking and tests each pair for a documented interaction. C.A.V.E. works the other way, testing one agent against one patient, screening a medicine against that person's diseases, allergies, age, kidney function, and similar attributes. The interaction check asks whether these medicines clash with each other; C.A.V.E. asks whether this medicine clashes with this patient. Both serve Arzneimitteltherapiesicherheit (AMTS), medication therapy safety, and on pharmazie.com they appear side by side as "CAVE / Interaktionen".
On pharmazie.com the interaction check reaches professionals through the licensed ABDA-Datenbank, next to the C.A.V.E. risk check.
One honest limitation: an interaction check reports documented interactions from coded product and literature data, and a severe grade still calls for clinical judgement about the individual patient. It is decision support for professionals, not a therapy decision.
